(Q35161148)

6 August 2017

1 reference

title

Prediction of cardiovascular risk in people with diabetes (English)

1 reference

6 August 2017

Winocour PH

1

1 reference

6 August 2017

Fisher M

series ordinal

2

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

20

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

515-527

1 reference

QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Cardiovascular mortality in hypertensive men according to presence of associated risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

A survey of biases in the measurement of plasma lipid and lipoprotein concentrations in 32 lipid clinics in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: cross sectional study of cardiovascular disease and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

The risk of determining risk with multivariable models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00934.X

10.1046/J.1464-5491.2003.00934.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference